Introduction

Stereotactic body radiotherapy (SBRT), also referred to as stereotactic ablative radiotherapy (SABR), is increasingly been used by radiation oncologists to treat a variety of tumors including most commonly those located in the lung, spine, liver, and pancreas. The principles of SBRT or SABR, including the use of hypofractionation and high-dose per fraction to achieve sharp dose gradients, can result in greater tumor control and better integration with other cancer therapies. However, this technology must be applied judiciously as the risk of harming patients is also increased.
Source: Seminars in Radiation Oncology - Category: Cancer & Oncology Authors: Source Type: research